BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11407518)

  • 21. Sentinel lymph node dissection provides axillary control equal to complete axillary node dissection in breast cancer patients with lobular histology and a negative sentinel node.
    Khakpour N; Hunt KK; Kuerer HM; Yi M; Meric-Bernstam F; Ross MI; Lucci A
    Am J Surg; 2005 Oct; 190(4):598-601. PubMed ID: 16164930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of axillary lymph node dissection in breast cancer patients with sentinel lymph node micrometastases.
    Gipponi M; Canavese G; Lionetto R; Catturich A; Vecchio C; Sapino A; Friedman D; Cafiero F
    Eur J Surg Oncol; 2006 Mar; 32(2):143-7. PubMed ID: 16300921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Does a Positive Axillary Lymph Node Needle Biopsy Result Predict the Need for an Axillary Lymph Node Dissection in Clinically Node-Negative Breast Cancer Patients in the ACOSOG Z0011 Era?
    Pilewskie M; Mautner SK; Stempel M; Eaton A; Morrow M
    Ann Surg Oncol; 2016 Apr; 23(4):1123-8. PubMed ID: 26553439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphatic invasion, tumor size, and age are independent predictors of axillary lymph node metastases in women with T1 breast cancers.
    Gajdos C; Tartter PI; Bleiweiss IJ
    Ann Surg; 1999 Nov; 230(5):692-6. PubMed ID: 10561094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathologic analysis of a large series of microinvasive breast cancers.
    Lillemoe TJ; Tsai ML; Swenson KK; Susnik B; Krueger J; Harris K; Rueth N; Grimm E; Leach JW
    Breast J; 2018 Jul; 24(4):574-579. PubMed ID: 29476574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of nonsentinel node metastasis in patients with breast cancer after sentinel node metastasis.
    Joseph KA; El-Tamer M; Komenaka I; Troxel A; Ditkoff BA; Schnabel F
    Arch Surg; 2004 Jun; 139(6):648-51. PubMed ID: 15197092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T1 breast cancer: identification of patients at low risk of axillary lymph node metastases.
    Bader AA; Tio J; Petru E; Bühner M; Pfahlberg A; Volkholz H; Tulusan AH
    Breast Cancer Res Treat; 2002 Nov; 76(1):11-7. PubMed ID: 12408371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Infiltrating breast carcinoma smaller than 0.5 centimeters: is lymph node dissection necessary?
    Saiz E; Toonkel R; Poppiti RJ; Robinson MJ
    Cancer; 1999 May; 85(10):2206-11. PubMed ID: 10326699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biopsy method and excision volume do not affect success rate of subsequent sentinel lymph node dissection in breast cancer.
    Haigh PI; Hansen NM; Qi K; Giuliano AE
    Ann Surg Oncol; 2000; 7(1):21-7. PubMed ID: 10674444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sentinel lymph node biopsy in patients with operable breast cancer treated with neoadjuvant chemotherapy.
    Rebollo-Aguirre AC; Gallego-Peinado M; Menjón-Beltrán S; García-García J; Pastor-Pons E; Chamorro-Santos CE; Ramos-Font C; Salamanca-Ballesteros A; Llamas-Elvira JM; Olea-Serrano N
    Rev Esp Med Nucl Imagen Mol; 2012; 31(3):117-23. PubMed ID: 21676504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preoperative axillary ultrasound and fine-needle aspiration biopsy in the diagnosis of axillary metastases in patients with breast cancer: predictors of accuracy and future implications.
    Cools-Lartigue J; Sinclair A; Trabulsi N; Meguerditchian A; Mesurolle B; Fuhrer R; Meterissian S
    Ann Surg Oncol; 2013 Mar; 20(3):819-27. PubMed ID: 22972506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast.
    Broekhuizen LN; Wijsman JH; Peterse JL; Rutgers EJ
    Eur J Surg Oncol; 2006 Jun; 32(5):502-6. PubMed ID: 16569492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Omission of axillary dissection after a positive sentinel node dissection may influence adjuvant chemotherapy indications in operable breast cancer patients.
    Montemurro F; Maggiorotto F; Valabrega G; Kubatzki F; Rossi V; Magistris A; Marocco F; Gatti M; Sarotto I; Aglietta M; Ponzone R
    Ann Surg Oncol; 2012 Nov; 19(12):3755-61. PubMed ID: 22805871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sentinel Lymph Node Biopsy and Isolated Tumor Cells in Invasive Lobular Versus Ductal Breast Cancer.
    Truin W; Roumen RM; Siesling S; van der Heiden-van der Loo M; Lobbezoo DJ; Tjan-Heijnen VC; Voogd AC
    Clin Breast Cancer; 2016 Aug; 16(4):e75-82. PubMed ID: 27116948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of metastasis to non-sentinel nodes by sentinel node status and primary tumor characteristics in primary breast cancer in Taiwan.
    Yu JC; Hsu GC; Hsieh CB; Sheu LF; Chao TY
    World J Surg; 2005 Jul; 29(7):813-8; discussion 818-9. PubMed ID: 15951935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
    Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
    Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of nonsentinel lymph node metastasis in breast cancer patients with one or two positive sentinel lymph nodes.
    Öz B; Akcan A; Doğan S; Abdulrezzak Ü; Aslan D; Sözüer E; Emek E; Akyüz M; Elmalı F; Ok E
    Asian J Surg; 2018 Jan; 41(1):12-19. PubMed ID: 27591153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors predicting the non-sentinel lymph node involvement in breast cancer patients with sentinel lymph node metastases.
    Boler DE; Uras C; Ince U; Cabioglu N
    Breast; 2012 Aug; 21(4):518-23. PubMed ID: 22410110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The changing landscape of axillary surgery: which breast cancer patients may still benefit from complete axillary lymph node dissection?
    McGhan LJ; Dueck AC; Gray RJ; Wasif N; McCullough AE; Pockaj BA
    J Surg Oncol; 2012 Sep; 106(3):254-9. PubMed ID: 22034211
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence of axillary lymph node metastases in T1a and T1b breast carcinoma.
    Port ER; Tan LK; Borgen PI; Van Zee KJ
    Ann Surg Oncol; 1998; 5(1):23-7. PubMed ID: 9524703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.